Dental News - Investing in growth: Septodont builds new production facilities

Search Dental Tribune

Investing in growth: Septodont builds new production facilities

The new Septodont building has been operational for several months. Headquartered in Saint-Maur-des-Fossés, the company has a long-standing presence in more than 150 countries. (Photograph: Septodont)

Tue. 18. April 2017


SAINT-MAUR-DES-FOSSÉS, France: Septodont, known for its dental pain management products, has built a new facility near Paris for the production of injectable dental anaesthetic cartridges. The company has invested nearly €26 million in the establishment of its new building. The production facility is part of a strategy based on internal growth and external acquisitions.

The new facility features clean rooms equipped with specialist air treatment systems, in addition to new production tanks and a high-speed cartridge filling line. By investing in this state-of-the-art equipment, Septodont aims to continue to deliver high pharmaceutical quality and guarantee product sterility. “Currently, we produce over 500 million injectable cartridges a year, half of it in France, and our new high-tech equipment helps us respect our commitment to consistently provide top-quality products to dentists,” Olivier Schiller, CEO of Septodont, explained.

“This new facility allows us to remain at the cutting edge of our sector in terms of production and at the same time to anticipate new international pharmaceutical standards,” said Schiller.

Construction began in April 2014 in Saint-Maur-des-Fossés, where the company’s headquarters and a recently completed research and development centre are also located. The new building, which covers three levels of 900 m² each, took two years to complete and has been fully operational since the end of 2016.

Septodont’s business has grown internally through geographical expansion and continued R & D investments. The new building complements three key acquisitions outside France in just two years: DLA (Brazil), a dental anaesthetic production facility formerly owned by DENTSPLY and acquired in February 2016 to drive growth in Latin America; Duoject (Canada), an engineering design business specialised in injection systems and solutions for health care, acquired in October 2015; and TDV Dental (Brazil), an industrial restorative accessory company with a wide range of dental products that complement Septodont’s own portfolio, acquired in 2014.

Septodont, a family business founded in 1932, has grown to become a leading dental manufacturer worldwide. As well as its reputation among dental professionals for a wide range of quality dental products, the company is internationally recognised for its expertise in pain management. “In addition to delivering quality products, we want to support dentists in their day-to-day practice, in particular by sharing our pain management expertise. Going forward, our ambition is to provide even more innovative solutions and become a global player in health care, beyond dentistry,” added Schiller.

To post a reply please login or register